Streamline Health Solutions Announces Merger with MDaudit

The latest announcement is out from Streamline Health Solutions ( (STRM) ).

On May 29, 2025, Streamline Health Solutions entered into a merger agreement with MDaudit, under which MDaudit will acquire all outstanding shares of Streamline for $5.34 per share in cash, representing a 138% premium over Streamline’s closing price on May 28, 2025. This merger aims to combine Streamline’s pre-bill integrity solutions with MDaudit’s billing compliance and revenue integrity platform, enhancing the ability to unify data silos and drive coordinated actions across the revenue cycle continuum, ultimately improving financial stability for healthcare organizations.

The most recent analyst rating on (STRM) stock is a Buy with a $22.50 price target. To see the full list of analyst forecasts on Streamline Health Solutions stock, see the STRM Stock Forecast page.

Spark’s Take on STRM Stock

According to Spark, TipRanks’ AI Analyst, STRM is a Neutral.

Streamline Health Solutions faces substantial financial instability due to negative growth and high leverage. Technical analysis indicates bearish momentum, compounded by a poor valuation. Despite some positive developments in the earnings call, significant challenges remain, particularly around revenue decline and liquidity concerns. These factors collectively contribute to a low overall stock score.

To see Spark’s full report on STRM stock, click here.

More about Streamline Health Solutions

Streamline Health Solutions, Inc. is a provider of solutions that enable healthcare providers to improve financial performance through integrated solutions, technology-enabled services, and analytics. The company focuses on addressing revenue leakage and enhancing financial performance across healthcare enterprises.

Average Trading Volume: 8,056

Technical Sentiment Signal: Sell

Current Market Cap: $9.53M

Find detailed analytics on STRM stock on TipRanks’ Stock Analysis page.